Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Development of a low-cost point-of-care test for Tuberculosis detection

  • Ramirez-Priego, Patricia
  • Lechuga, Laura M.
Resumen del póster presentado al VIII International Congress on Analytical Nanoscience and Nanotechnology, celebrado en Barcelona (España) del 3 al 5 de julio de 2017.-- et al., Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a re-emerging disease impacting global health and affecting around 10.4 million people annually, with 1.8 million deaths. Registered incidence rates are low due to the lack of rapid and accurate diagnostic tools, especially in low-resource countries, posing serious hurdles for TB control. Since several years ago, a major effort is directed to develop a point-of-care (PoC) platform to facilitate the prompt and reliable TB diagnostics at low cost. In the frame of the European FP7 Pocket project, we have developed a novel PoC platform for the non-invasive technique detection of TB in human urine, accomplishing the above requirements. The new tuberculosis PoC is based on the combination of highly sensitive Mach-Zehnder integrated interferometers with an on-chip spectral filter, combined with a polymer microfluidic cartridge (disposable part), a SLED light source, a CCD camera for read-out and a graphical user interface for data processing. All the elements are incorporated in a PoC platform. The TB detection is achieved directly in the urine samples by an immunoassay employing high quality and selective antibodies against M. tuberculosis cell wall lipopolysaccharide lipoarabinomannan (LAM) and Ag85 complex. A preliminary Limit of Detection (LoD) of 956 pg/mL and 8.496 ng/mL for LAM and Ag85, respectively, have been achieved., European FP7 Pocket project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A low-cost integrated biosensing platform based on SiN nanophotonics for biomarker detection in urine

  • Martens, Daan
  • Ramirez-Priego, Patricia
  • Murib, M. S.
  • Elamin, Ayssar A.
  • González-Guerrero, Ana Belén
  • Stehr, M.
  • Jonas, F.
  • Anton, Birgit
  • Hlawatsch, N.
  • Soetaert, Pieterjan
  • Vos, Rita
  • Stassen, A.
  • Severi, S.
  • Van Roy, Wim
  • Bockstaele, Ronny
  • Becker, Holger
  • Singh, Mahavir
  • Lechuga, Laura M.
  • Bienstman, Peter
We present a low-cost integrated nanophotonic lab-on-a-chip platform suitable for point-of-care (POC) biomarker analysis. The sensor chip included in the platform contains multiplexed Mach–Zehnder interferometers with an on-chip optical spectral analyser consisting of an arrayed-waveguide grating. The sensor chip is fabricated in silicon nitride material, which makes it compatible with consumer-electronics-grade sources and detectors, leading to the possibility of low-cost instrumentation. The nanophotonic sensor chip exhibits a detection limit of 6 × 10−6 RIU (Refractive Index Units), which is in the same order of magnitude as the reported values for state-of-the-art evanescent wave sensors. The sensor chip is biofunctionalised with specific bioreceptors and integrated into a polymer microfluidic cartridge. The POC instrumentation platform contains optical excitation and read-out sub-systems and dedicated on-board software for real-time analysis of patient samples. To demonstrate the versatility of the platform, we present results both on the detection of an antigen related to tuberculosis directly in urine samples using a laboratory prototype and on the detection of a protein biomarker (CRP) related to inflammation using the integrated instrument., This work was funded by the European Commission under the FP7 project Pocket (grant 610389). The nanoB2A is a consolidated research group (Grup de Recerca) of the Generalitat de Catalunya and has support from the Departament d'Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya (2014 SGR 624). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa programme of the Spanish Ministry of Economy, Industry and Competitiveness (MINECO, Grant no. SEV-2013-0295)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Label-free and real-time detection of tuberculosis in human urine samples using a nanophotonic point-of-care platform

  • Ramirez-Priego, Patricia
  • Martens, Daan
  • Elamin, Ayssar A.
  • Soetaert, Pieterjan
  • Van Roy, Wim
  • Vos, Rita
  • Anton, Birgit
  • Bockstaele, Ronny
  • Becker, Holger
  • Singh, Mahavir
  • Bienstman, Peter
  • Lechuga, Laura M.
Tuberculosis (TB) is the leading global cause of death from a single infectious agent. Registered incidence rates are low, especially in low-resource countries with weak health systems, due to the disadvantages of current diagnostic techniques. A major effort is directed to develop a point-of-care (POC) platform to reduce TB deaths with a prompt and reliable low-cost technique. In the frame of the European POCKET Project, a novel POC platform for the direct and noninvasive detection of TB in human urine was developed. The photonic sensor chip is integrated in a disposable cartridge and is based on a highly sensitive Mach–Zehnder Interferometer (MZI) transducer combined with an on-chip spectral filter. The required elements for the readout are integrated in an instrument prototype, which allows real-time monitoring and data processing. In this work, the novel POC platform has been employed for the direct detection of lipoarabinomannan (LAM), a lipopolysaccharide found in the mycobacterium cell wall. After the optimization of several parameters, a limit of detection of 475 pg/mL (27.14 pM) was achieved using a direct immunoassay in undiluted human urine in less than 15 min. A final validation of the technique was performed using 20 clinical samples from TB patients and healthy donors, allowing the detection of TB in people regardless of HIV coinfection. The results show excellent correlation to those obtained with standard techniques. These promising results demonstrate the high sensitivity, specificity and applicability of our novel POC platform, which could be used during routine check-ups in developing countries., This work was funded by the European Commission under the FP7 project Pocket (Grant 610389). The ICN2 is funded by the CERCA programme/Generalitat de Catalunya. The ICN2 is supported by the Severo Ochoa programme of the Spanish Ministry of Economy, Industry and Competitiveness (MINECO, Grant No. SEV-2013-0295)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Label-Free and Real-Time Detection of Tuberculosis in Human Urine Samples Using a Nanophotonic Point-of-Care Platform

  • Ramirez Priego, Patricia|||0000-0001-5657-3279
  • Martens, Daan
  • Elamin, Ayssar A.
  • Soetaert, Pieterjan
  • Van Roy, Wim
  • Vos, Rita
  • Anton, Birgit
  • Bockstaele, Ronny
  • Becker, Holger
  • Singh, Mahavir
  • Bienstman, Peter
  • Lechuga, Laura M|||0000-0001-5187-5358
Tuberculosis (TB) is the leading global cause of death from a single infectious agent. Registered incidence rates are low, especially in low-resource countries with weak health systems, due to the disadvantages of current diagnostic techniques. A major effort is directed to develop a point-of-care (POC) platform to reduce TB deaths with a prompt and reliable low-cost technique. In the frame of the European POCKET Project, a novel POC platform for the direct and noninvasive detection of TB in human urine was developed. The photonic sensor chip is integrated in a disposable cartridge and is based on a highly sensitive Mach-Zehnder Interferometer (MZI) transducer combined with an on-chip spectral filter. The required elements for the readout are integrated in an instrument prototype, which allows real-time monitoring and data processing. In this work, the novel POC platform has been employed for the direct detection of lipoarabinomannan (LAM), a lipopolysaccharide found in the mycobacterium cell wall. After the optimization of several parameters, a limit of detection of 475 pg/mL (27.14 pM) was achieved using a direct immunoassay in undiluted human urine in less than 15 min. A final validation of the technique was performed using 20 clinical samples from TB patients and healthy donors, allowing the detection of TB in people regardless of HIV coinfection. The results show excellent correlation to those obtained with standard techniques. These promising results demonstrate the high sensitivity, specificity and applicability of our novel POC platform, which could be used during routine check-ups in developing countries.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A low-cost integrated biosensing platform based on SiN nanophotonics for biomarker detection in urine

  • Martens, Daan
  • Ramirez Priego, Patricia|||0000-0001-5657-3279
  • Murib, M. S.
  • Elamin, Ayssar A.
  • González-Guerrero, Ana Belén|||0000-0002-4871-9642
  • Stehr, M.
  • Jonas, F.
  • Anton, Birgit
  • Hlawatsch, N.
  • Soetaert, Pieterjan
  • Vos, Rita
  • Stassen, A.
  • Severi, S.
  • Van Roy, Wim
  • Bockstaele, Ronny
  • Becker, Holger
  • Singh, Mahavir
  • Lechuga, Laura M|||0000-0001-5187-5358
  • Bienstman, Peter
We present a low-cost integrated nanophotonic lab-on-a-chip platform suitable for point-of-care (POC) biomarker analysis. The sensor chip included in the platform contains multiplexed Mach-Zehnder interferometers with an on-chip optical spectral analyser consisting of an arrayed-waveguide grating. The sensor chip is fabricated in silicon nitride material, which makes it compatible with consumer-electronics-grade sources and detectors, leading to the possibility of low-cost instrumentation. The nanophotonic sensor chip exhibits a detection limit of 6 × 10 RIU (Refractive Index Units), which is in the same order of magnitude as the reported values for state-of-the-art evanescent wave sensors. The sensor chip is biofunctionalised with specific bioreceptors and integrated into a polymer microfluidic cartridge. The POC instrumentation platform contains optical excitation and read-out sub-systems and dedicated on-board software for real-time analysis of patient samples. To demonstrate the versatility of the platform, we present results both on the detection of an antigen related to tuberculosis directly in urine samples using a laboratory prototype and on the detection of a protein biomarker (CRP) related to inflammation using the integrated instrument.